Login / Signup

Effects of COVID-19 Pandemic and Lockdown on Monitoring and Treatment Balance of Finnish Coronary Heart Disease and Type 2 Diabetes Patients.

Piia LavikainenMarja-Leena LamidiTeppo RepoLaura InglinJanne MartikainenTiina Laatikainen
Published in: Clinical epidemiology (2022)
The lockdown decreased the frequency of monitoring among both CHD and T2D patients. Meanwhile, monthly average LDL had a steadily improving pattern in CHD patients during the follow-up while temporary worsening in HbA1c in patients with T2D was observed at the time of the lockdown. The lockdown may have introduced selection in patients who had their treatment outcomes monitored. Better self-management of risk factors among patients is also possible.
Keyphrases
  • end stage renal disease
  • type diabetes
  • newly diagnosed
  • ejection fraction
  • risk factors
  • chronic kidney disease
  • prognostic factors
  • adipose tissue
  • patient reported outcomes
  • insulin resistance
  • patient reported